The deal appears to require CSR to give certain assurances about its asbestos liabilities before any return of capital to shareholders from proceeeds can be undertaken. These assurances include allowing an additional independent body to review asbestos liabilities as well as a 'big 4' accounting firm to give an opinion about the ability of the company to meet its obligations. Hopefully, adequate allocations of proceeds by the board for asbestos liabilities and to reduce debt levels will satisfy these requirements.
CSR Price at posting:
$5.37 Sentiment: Hold Disclosure: Held
